191 related articles for article (PubMed ID: 10481776)
1. [Organ-preserving treatment of bladder cancer with combined radiochemotherapy: Do patients profit from additional neoadjuvant chemotherapy?].
Diestelhorst A; Dunst J
Strahlenther Onkol; 1999 Aug; 175(8):414-5. PubMed ID: 10481776
[No Abstract] [Full Text] [Related]
2. Neoadjuvant treatment for invasive bladder cancer: is it worthwhile?
Hall RR
Acta Urol Belg; 1996 May; 64(2):39-42. PubMed ID: 8701809
[No Abstract] [Full Text] [Related]
3. [Neoadjuvant chemotherapy for invasive bladder cancer].
Kageyama Y; Kihara K
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1838-44. PubMed ID: 11729476
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive adjuvant or neoadjuvant chemotherapy for locally advanced bladder cancer: a critical appraisal of the present status.
Walther PJ
Semin Urol; 1993 Nov; 11(4):227-34. PubMed ID: 8290828
[No Abstract] [Full Text] [Related]
5. Plenary debate of randomized phase III trial of neoadjuvant MVAC plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer.
Bajorin DF
J Clin Oncol; 2001 Sep; 19(18 Suppl):17S-20S. PubMed ID: 11560966
[No Abstract] [Full Text] [Related]
6. Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer.
Sternberg CN; Parmar MK
J Clin Oncol; 2001 Sep; 19(18 Suppl):21S-26S. PubMed ID: 11560967
[No Abstract] [Full Text] [Related]
7. Overview of systemic treatment of bladder cancer and results with M-VAC therapy.
Yagoda A
Prog Clin Biol Res; 1990; 350():87-99. PubMed ID: 2201047
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
9. [Neoadjuvant chemotherapy in muscle-invasive bladder cancer].
Miyanaga N; Akaza H
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1745-9. PubMed ID: 18030008
[TBL] [Abstract][Full Text] [Related]
10. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
Birtle AJ; Huddart RA
BJU Int; 2006 Jun; 97(6):1348; author reply 1348-50. PubMed ID: 16686740
[No Abstract] [Full Text] [Related]
11. Treatment of high-stage bladder cancer: case for adjunctive chemotherapy.
Walther PJ
Semin Urol; 1993 May; 11(2):69-73. PubMed ID: 8362122
[No Abstract] [Full Text] [Related]
12. Chemotherapy for advanced urothelial cancer.
Yagoda A
Semin Urol; 1983 Feb; 1(1):60-74. PubMed ID: 6382528
[No Abstract] [Full Text] [Related]
13. Muscle-invasive urothelial carcinoma of the bladder: neoadjuvant chemotherapy enables organ-preserving therapy in carefully selected patients.
Heidenreich A
Eur Urol; 2008 Jul; 54(1):21-3. PubMed ID: 18262722
[No Abstract] [Full Text] [Related]
14. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy for non-organ confined bladder transitional cell carcinoma.
Abi-Aad AS
Acta Urol Belg; 1996 May; 64(2):35-7. PubMed ID: 8701808
[No Abstract] [Full Text] [Related]
16. Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies.
Sherif A; Holmberg L; Rintala E; Mestad O; Nilsson J; Nilsson S; Malmström PU;
Eur Urol; 2004 Mar; 45(3):297-303. PubMed ID: 15036674
[TBL] [Abstract][Full Text] [Related]
17. [Characteristic and effective usage of adriamycin].
Horiuchi K; Akimoto M
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1916-9. PubMed ID: 8978797
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95).
Lehmann J; Retz M; Wiemers C; Beck J; Thüroff J; Weining C; Albers P; Frohneberg D; Becker T; Funke PJ; Walz P; Langbein S; Reiher F; Schiller M; Miller K; Roth S; Kälble T; Sternberg D; Wellek S; Stöckle M;
J Clin Oncol; 2005 Aug; 23(22):4963-74. PubMed ID: 15939920
[TBL] [Abstract][Full Text] [Related]
19. Bladder cancer "adjuvant-lite": tastes great (works as well) and less filling (less toxic)?
Galsky MD; Scher HI
J Clin Oncol; 2005 Aug; 23(22):4823-6. PubMed ID: 15939919
[No Abstract] [Full Text] [Related]
20. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial.
Droller MJ
J Urol; 2000 May; 163(5):1602-3. PubMed ID: 10798921
[No Abstract] [Full Text] [Related]
[Next] [New Search]
